Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma

OBJECTIVE: Currently, there is no standard adjuvant treatment protocol for localized uterine leiomyosarcoma (uLMS) as clinical trials to address this question have been retrospective, underpowered, or undermined by slow accrual rates. The aim of this study is to determine the benefit of adjuvant che...

Descripción completa

Detalles Bibliográficos
Autores principales: Chantharasamee, Jomjit, Wong, Karlton, Potivongsajarn, Pasathorn, Qorbani, Amir, Motamed, Neda, Brackert, Sandra, Cohen, Joshua, Chmielowski, Bartosz, Kalbasi, Anusha, Rao, Jianyu, Nelson, Scott, Singh, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359871/
https://www.ncbi.nlm.nih.gov/pubmed/35307963
http://dx.doi.org/10.1002/cam4.4665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359871/
https://www.ncbi.nlm.nih.gov/pubmed/35307963
http://dx.doi.org/10.1002/cam4.4665

Ejemplares similares